throbber
Cell, Vol. 120, 99—110, January 14, 2005, Copyright ©2005 by Elsevier lnc.
`
`DOI 10.1 01 6/].cell.2004.11.032
`
`Coordinated Remcdeling sf Gelluiar
`Metabolism during Iron fieficieacy
`through Targeted mRMA Degradation
`
`Sergi Puig,“ Eric Askeland,‘ and Dennis J. Thiele’”
`‘Department of Pharmacology and Cancer Biology
`Sarah W. Stedman Nutrition and Metabolism Center
`Duke University Medical Center
`Research Drive-LSRC-0351
`Durham, North Carolina 27710
`
`Summary
`
`Iron (Fe) is an essential micronutrient for virtually all
`organisms and serves as a cofactor for a wide variety
`of vital cellular processes. Although Fe deficiency is
`the primary nutritional disorder in the world, cellular
`responses to Fe deprivation are poorly understood.
`We have discovered a posttranscriptional regulatory
`process controlled by Fe deficiency, which coordi-
`nately drives widespread metabolic reprogramming.
`We demonstrate that, in response to Fe deficiency,
`the Saccharomyces cerevisiae Cth2 protein specifi-
`cally downregulates mRNAs encoding proteins that
`participate in many Fe-dependent processes. mRNA
`turnover requires the binding of Cth2, an RNA binding
`protein conserved in plants and mammals, to specific
`AU~rich elements in the 3’ untranslated region of
`mRNAs targeted for degradation. These studies eluci-
`date coordinated global metabolic reprogramming in
`response to Fe deiiciency and identify a mechanism
`for achieving this by targeting specific mRNA mole-
`cules for degradation, thereby facilitating the utiliza-
`tion of limited cellular Fe levels.
`
`introduction
`
`Iron (Fe) is an essential nutrient for virtually all organ-
`isms. Fe serves as a cofactorfor a wide variety of cellular
`processes, including oxygen transport, cellular respira-
`tion, the tricarboxylic acid (TCA) cycle, lipid metabolism,
`synthesis of metabolic intermediates, gene regulation,
`and DNA replication and repair. Despite its abundance
`in the earth’s crust, Fe bioavailability is highly restricted
`due to its extreme insolubility at physiological pH. In-
`deed, Fe deficiency is the primary nutritional disorder
`in the world, estimated to affect over two billion people
`and resulting in iron deficiency anemia (Baynes and
`Bothwell, 1990). Alterations in iron homeostasis underlie
`many human diseases, including Friedreich’s ataxia, he-
`reditary hemochromatosis, aceruloplasminemia, Par-
`kinson’s disease, aging, microbial pathogenesis, and
`cancer (Hentze et al., 2004; Nittis and Gitlin, 2002; Roy
`and Andrews, 2001).
`Elegant genetic, biochemical, and physiological stud-
`ies have elucidated many of the components that func-
`tion in Fe uptake, efflux, and distribution and their mechs
`
`‘Correspondence: dennis.thiele@duke.edu
`1 Present address: Departament de Bioquimica i Biologia Molecular,
`Universitat de Valencia, Avenida Dr. Moliner 50, E461 00 Buriassot,
`Valencia. Spain.
`
`anisms of action in both prokaryotic and eukaryotic cells
`(Escolar et al., 1909; Hentze et al., 2004; Van Ho et al.,
`2002). Studies with the baker’s yeast Saccharomyces
`cerevisiae have demonstrated that, in response to Fe
`deprivation, cells utilize the Fe-responsive transcription
`factors Am and Aim to induce expression of the so-
`called iron regulon (Rutherford et al., 2003; Shakoury-
`Elizeh et al., 2004), which includes proteins involved in
`Fe reduction at the plasma membrane, uptake, mobiliza-
`tion from intracellular stores, and utilization from heme,
`among others (Van Ho et al., 2002). Less attention has
`been dedicated to the characterization of metabolic
`pathways that are specifically downregulated by Fe
`depletion. Recent studies have shown that mRNA levels
`of genes involved in biotin synthesis, glutamate metabo-
`lism and heme assembly are downregulated under low
`Fe conditions (Lesuisse et al., 2003; Shakoury-Elizeh et
`al., 2004). However, the mechanisms controlling the Fe
`deprivation-dependent downregulation of these genes,
`and other global metabolic pathways altered as a conse
`quence of Fe deficiency, have not been elucidated.
`In mammals, one response to iron scarcity is posttran-
`scriptionally controlled by the iron—regulatory proteins
`IRP1 and lRP2. In response to Fe deprivation, lRP1 binds
`to specific mRNA stem-loop structures known as iron-
`responsive elements (IRES). lRPi binding to IRES in the
`5’ untranslated region inhibits translation of erythroid
`aminolevulinic acid synthase, mitochondrial aconitase,
`the ferroportin Fe efflux pump, and subunits of the Fe
`storage protein ferritin. IRP1 binding to lREs in the 3’
`untranslated region (3’UTR) of the transferrin receptor 1
`isoform stabilizes the mRNA, thereby increasing protein
`levels and enhancing Fe uptake via Fe loaded transferrin
`(Hentze et al., 2004; Theil, 2000). A posttranscriptional
`downregulation of Fe-dependent pathways, which de-
`pends on small antisense RNAs, has recently been de-
`scribed in bacteria (Masse and Gottesman, 2002; Wil-
`derman et al., 2004).
`While several dozen metabolic enzymes require Fe
`for catalysis in eukaryotic cells, little is known about
`global reprogramming and regulatory mechanisms gov-
`erning this process in response to Fe deficiency. We
`have discovered a mechanism that mediates global
`posttranscriptional control of multiple components of
`Fe-dependent pathways to respond in a concerted fash-
`ion to Fe deficiency. The Fe—regulated protein Cth2 coor—
`clinates this process by binding to and targeting specific
`mRNA molecules for degradation under Fe deficiency,
`thereby facilitating the utilization of limited available Fe
`for normal growth.
`
`Results
`
`Genome-Wide Response of Saccharomyces
`cerevisiae to iron Deprivation
`Although Fe plays a crucial role in a wide array of ceilular
`processes, little is known about how Fe deprivation af-
`fects metabolic pathways on a global scale in eukaryotic
`cells. To investigate the response of S. cerevisiae to Fe
`
`BUTAMAX 1006
`
`

`

`Cell
`1 00
`
`Downregu‘iated
`
`Upregulated
`
`iron reguion'
`
`Sterol and unsaturated fatty acid synthesis
`
`, Trécarboxylic acid cycle
`:- Electron transport chain
`Heme and Fees proteinslbiosynthesis
`
`Biotin synthesis
`
`DNA replication and repair
`
`.3,
`
`i
`
`;;
`
`I
`
`
`
`
`20
`
`1O
`
`0
`
`10
`
`20
`
`Number of genes
`Figure 1 . Response of Pea-Dependent Processes to Fe Depletion in Yeast
`B4741 wild—type cells were grown in SC containing 300 pM Fe or 100 pM BPS, and RNA was analyzed with DNA microarrays as detailed in
`Experimental Procedures. Only components of multiple Fe-dependent pathways with a fold change greater than two have been represented.
`A list of the genes grouped in each functional family Es shown in Supplemental Tables 82 and SS.
`
`deprivation, we compared the mRNA expression profile
`of wild-type cells grown under Fe—replete conditions to
`cells grown under Fe scarcity achieved by addition of
`the Fe(ll) chelator bathophenantholine disulfonic acid
`(BPS). We observed that, in addition to changes in other
`processes (data not shown), key components of multiple
`Fe-dependent metabolic pathways are significantly al-
`tered by Fe availability (Figure 1 and see Supplemental
`Tables 82 and $3 at http://www.celLoom/cgi/content/
`full/120l1/99/DC‘H’). in addition to the induction of the
`Aft1/2-dependent Fe regulon previously described
`(Blajseau et al., 2001; Rutherford et al., 2003; Shakoury-
`Elizeh et al., 2004; Yamaguchi-lwai et al., 1996), genes
`involved in sterol biosynthesis (ERG genes) and the fatty
`acid desaturase OLE1 are induced under Fe deprivation.
`In addition, key components of multiple Fe=dependent
`pathways and proteins including (1) the TCA cycle; (2)
`the mitochondrial electron transport chain; (3) Fe—S clus-
`ter, di-Fe-tyrosyl, and heme—containing proteins; and, (4)
`as recently described (Lesuisse et al., 2003; Shakoury-
`Elizeh et al., 2004), HEM15 encoding ferrochelatase, the
`last step in heme biosynthesis, and two enzymes in-
`volved in biotin synthesis are coordinately downregu-
`lated by Fe depletion (Figure1 and Supplemental Table
`83). Taken together, these results demonstrate that
`mFiNA levels of multiple components of Fe—dependent
`metabolic pathways in S. cerevisiae are coordinately
`regulated in response to Fe deprivation.
`
`The Aft1-A’ft2 Target CTH2 is important for Growth
`under Fe Limitation
`
`Previous DNA microarray experiments strongly suggest
`that the CTH2 gene, which encodes a protein related to
`the mammalian tandem zinc finger (TZF) protein triste—
`traprolin or TTP (Figure 2A), is transcriptionally induced
`under Fe limitation (Foury and Talibi, 2001; Rutherford
`et al., 2003; Shakoury-Elizeh et al., 2004). As shown in
`Figures 28 and 2C, the steady-state levels of CTH2
`mRNA and a functional FLAG epitope-tagged 0ch pro-
`tein under Fez—adequate conditions are very low but dra-
`matically increase in response to Fe deprivation. Fur~
`
`thermore, CTH2 expression under low Fe conditions is
`significantly decreased in an aft1 strain and is undetect-
`able under either condition in the aft1aft2 double mutant.
`Mutagenesis of two putative Aft1-Aft2 binding sites (Ya—
`maguchi-lwai et al., 1996) from the CTH2 upstream
`sequence indicates that both sites cooperate in the acti-
`vation of CTH2 by Fe starvation, although these experi-
`ments do not exclude the participation of other cis-
`regulatory sequences in CTH2 regulation by Fe (see
`Suppiemental “Figure 82 on the Cell web site).
`Given that CTH2 mRNA levels are tightly regulated by
`Fe availability and the Aft1 -Aft2 Fe—responsive transcrip-
`tion factors, we assayed growth of cth2 deletion mutant
`cells under Fe deprivation conditions. cth2 cells exhib-
`ited a growth defect compared to wild-type cells in the
`presence of the intracellular Fe-speciféc chelator ferroz—
`ine (Figure 3A). The cch growth defect on ferrozine was
`reversed by addition of Fe (Figure 3A), demonstrating
`that the growth defect of cth2 cells occurs in response
`to Fe deprivation rather than to ferrozine administration.
`The yeast genome harbors a gene encoding a protein
`similar to Cth2, Cth1 (Thompson et al., 1996), whose
`transcription is independent of Fe levels (Figure 23).
`Although cth1 cells did not display a growth defect under
`Fe deprivation conditions, cells lacking both CTH1 and
`CTH2 exhibited a more severe growth defect than those
`lacking only 07222 (Figure 3A). Similarly, the cth1cth2
`growth defect in the presence of ferrozine was partially
`suppressed by CTH1 and completely recovered by
`coexpression of both CTH1 and CTH2 (Figure 3B). These
`results demonstrate that CTH2 is important for growth
`under Fe deprivation induced by the membrane perme-
`able Fe chelator ferrozine and suggest that Cth1 function
`in yeast cells may partially overlap with Cth2.
`
`CTH2 Coordinates the Downregulation of Multiple
`Fe-Dependent Pathways under Fe Deprivation
`A prominent feature of Cth2 is the presence of a
`stcxscst tandem zinc finger (TZF) domain near the
`carboxyl terminus of the protein (Figure 2A and Supple—
`mental Figure 81). This TZF motif is present in a family of
`
`

`

`1
`1
`06m Controls a Posttranscriptional Fe Regulon
`
`
`
`B
`
`0
`
`aft1
`WT aft1 aftz aftz
`Fe '+—..-'
`'+_-‘ T. at".
`g as
`.15:
`
`g»
`
`«sag
`
`CTH2
`
`FET3
`
`
`
`W“*‘§%§eww A03
`
`Flagz
`
`Cth2
`vector
`
`Fe+-+-
`
`Figure 2. Expression of CTH2 upon Fe Depletion ls Dependent on
`Both Aftt and Aft2 Transcription Factors
`(A) Model for the primary structure of S. cerevisiae Cth2 and Cth‘l
`and human tristetraprolin (hTi'P) protein. TZF, tandem zinc finger.
`(B) CM3260 wild-type, aft1, aft2, and aftlaft2 cells were grown in
`SC containing 100 pM Fe (Fe +) or 100 pM BPS (Fe —) and RNA
`extracted and analyzed by RNA blotting. The Aft1 target F573 was
`used as a control for Fe=regulated expression.
`(0) cth1cth2 cells transformed with pRS416-FLAG2-GTH2 or
`pFiS416 (vector) were grown in SC-Ura containing 300 pM Fe (Fe +)
`or 100 uM BPS (Fe -) and protein extracted and analyzed by immu-
`noblotting. Phosphoglycerate kinase (ng1) was used as a load—
`ing control.
`
`RNA binding proteins typified by the mammalian protein
`tristetraprolin (TTP). TTP mediates the targeted destabi-
`lization of tumor necrosis factor a UNFa), cyclooxygen-
`ass-2, interleukin-3, and granulocyte/macrophage col-
`ony-stimulating factor (GM-CSF) mRNAs (Blackshear,
`2002; Carballo et al.,
`1 998; Sawaoka et al., 2003;
`Stoecklin et al., 2001). An alignment of yeast Cth1 and
`Cth2 with human TTP shows that, while Cth1 and Cth2
`proteins share 46% identity, hTTP homology to Ctht
`and Cth2 is restricted to the TZF domains (Supplemental
`Figure S1). Despite little homology in the rest of the
`protein, we hypothesized that (3ch could be involved
`in posttranscriptional regulation of specific mRNAs un-
`der Fe deprivation. To test this hypothesis, we ascer-
`tained the effect of Cth2 on multiple mRNAs we ob-
`served in our microarray to be downregulated by Fe
`deficiency. As shown in Figure 3C, genes encoding pro«
`teins involved in the TCA cycle (SDH4), heme synthesis
`(HEM15), Fe-S cluster assembly (ISA 1), vacuolar Fe ac-
`cumulation (0001), and Fe—S proteins (LIP5) are dramat-
`ically downregulated under Fe starvation in a wild-type
`strain. The mRNA levels of RNR2, encoding a subunit
`of the essential di—Fe-tyrosil-dependent enzyme ribonu-
`
`cleotide reductase, are only modestly decreased by Fe
`deprivation (Figure 36). Interestingly, this coordinated
`mRNA downregulation does not occur in the absence
`of CTH2 (Figure 3C, wt versus cth2 mutant). While mRNA
`levels in cth1 cells did not change significantly with
`respect to wild-type cells, the cth1cth2 mutant dis-
`played reduced mRNA downregulation, suggesting that
`Cth1 directly or indirectly influences in this process.
`These results demonstrate that Cth2 functions in the
`downregulation of specific mRNAs under conditions of
`Fe deprivation.
`We used DNA microarrays to ascertain which mRNAs
`exhibit CTH2-dependent changes on a genome-wide
`scale by comparing the gene expression profiles under
`Fe deficiency of cth1cth2 cells expressing a plasmid-
`borne CTH2 gene or transformed with vector alone.
`Messenger RNAs corresponding to 84 genes were sig-
`nificantly upregulated in the absence of CTH2 (Table 1).
`lnterestingfy, 54% (45 of 84) of the upregulated genes
`are involved in obvious Feedependent processes, 14%
`(1 2 of 84) have other functions, and 32% (27 of 87) are
`genes of unknown function. Among the 45 Fe-related
`genes whose expression is increased in cth2 mutants
`under low Fe conditions compared to wild-type cells,
`we find (1) three members of the Fe regulon (FIT1, FIT2,
`and HMX1); (2) genes encoding key enzymes involved
`in heme biosynthesis (HEM15); (3) two genes encoding
`proteins involved in Fe—S cluster assembly (ISA1 and
`NFU1);
`(4) eight genes encoding enzymes that parti-
`cipate in the TCA cycle including aconitase (A001),
`succinate dehydrogenase subunits SDH2 and SDH4,
`a-ketoglutarate dehydrogenase (K601), and dihydroly-
`poyl transsuccinylase (KGD2); (5) 15 genes encoding
`proteins that participate in the electron transfer chain
`that include four subunits of the cytocrome c oxidase
`(COX4, COX6, COX8, COX9) and six subunits of the
`ubiquinol cytochrome c reductase complex (0031-5
`and RIP1); (6) eight members of the sterol and unsatu-
`rated fatty acid synthesis and metabolism pathways
`(ERG genes and OLE1); (7) ribonucleotide—diphosphate
`reductase subunits (RNR4); and (8) genes encoding ad-
`ditional Fe-S cluster-containing proteins (LIP5, encod-
`ing lipoic acid synthase; LEU1, required for leucine bio-
`synthesis; and RL! 1, related to RNase L inhibitor). Taken
`together, these results demonstrate that Cth2 functions
`in the coordinated downregulation of multiple Fe-depen-
`dent metabolic pathways, and potentially other as yet
`uncharacterized pathways, in yeast under conditions of
`Fe deficiency.
`
`A Conserved RNA Binding Motif Is Required
`for Cth2-Mediated mRNA Downregulation
`Studies with TTP in mammalian systems have demon-
`strated that the integrity of the zinc finger domains is
`required for binding and destabilization of specific
`mFtNAs (Blackshear, 2002; Lai et al., 1999, 2003). We
`tested the role of the CCCH zinc fingers in Cth2-depen-
`dent mRNA downregulation by mutagenizing conserved
`cysteine residues, located in both zinc finger motifs, to
`arginine. First, cells expressing CTH2-C190R or CTH2-
`0213R mutant alleles displayed a growth defect in the
`presence of the Fe-chelator ferrozine (Figure 3E). Sec-
`ond, Cth2-dependent downregulation of SDH4, HEM 15,
`
`

`

`Cell
`102
`
`A
`
`_
`Complete F'errozine
`
`Ferrozine
`+ Fe
`
`
`
` ctm
`
`'
`
`CTH2 .
`
`-
`

`
`(:ch
`
`CTH1 + CTH2 ..
`
`cth1
`WT (:ch c1h'1 (:ch
`l"—II—!f_“"lr‘—"i
`Fe+-+-+-+-
`
`a!“ fit
`
`
`
`
`
`
`
`ctm cthz
`
`CTH2 vector C1981? 6213}?
`
`Figure 3. CTH2 Is Required for Fe—Limited Growth and Fe Deficiency-Dependent mRNA Downregulation
`(A) BY4741 wild-type, cthl, cth2, and cth1cth2 cells were assayed for growth on SC (Complete) and SC containing 750 uM ferrozine without
`or with 300 uM Fe (t Fe).
`(B) cth1cth2 cells cotransformed with pRS416 plus pRS415 (vector), pRS416-CTH1 plus pRS415 (CTH1), pRS416 plus pRS415—CTH2 (CTH2;
`and pRS416-CTH1 plus pRS415-CTH2 (CTH1 + CTH2) were assayed on SC-Ura-Leu (—Ura — Lou) and SC containing 750 pM ferrozine.
`(C) CTH2 is essential for Fe deficiency-dependent mRNA downregulation. Wild-type cth2, cth1, and cth1cth2 cells were grown in SC media
`containing 300 uM Fe (Fe +) or 100 uM BPS (Fe —) and RNA extracted and analyzed by RNA blotting.
`(D) Schematic representation of the CCCH TZF domain in 0ch protein. Cysteine residues 190 and 213 (white characters) were mutagenized
`to arginine.
`(E) The 0ch TZF domains are essential for growth in the presence of ferrozine. BY4741 wild-type and cth2 cells transformed with vector
`alone or expressing CTH2, CTH2-C1908, and C7742—C213Fl alleles were assayed fog growth on ferrozine plates.
`(F) The 6ch CCCH TZF motifs are essential for mRNA downregulation. cth1cth2 cells containing vector or expressing CTH2, CTH2-C190Fl,
`and 07142-0213}? alleles were analyzed by RNA blotting as described for (C).
`
`LIPS, COX6, and other mRNAs (data not shown) was
`abrogated in both (3ch mutants (Figure 3F). Similar re-
`sults were obtained when cysteine residues 190 and 213
`were mutagenized to alanine (data not shown). Control
`experiments showed that the cysteine mutant proteins
`are properly expressed (data not shown). Taken to-
`gether, these results demonstrate that the integrity of
`both CCCH zinc finger motifs is essential for 0ch func-
`tion in coordinated mRNA downregulation in response
`to Fe deprivation.
`
`Downregulation of Specific mRNAs by Fe
`Deprévation Requires AU—Rich Elements
`Human Tl'P binds to AU-rich elements (ARES) within the
`3’UTR of target mRNAs and induces RNA degradation
`(Blackshear et al., 2003; Lai et at, 1999). interestingly,
`in silico analysis and visual inspectfon reveals that ap-
`proximately 80% of the mFlNAs upregulated in cch cells
`
`under low Fe conditions contain one or more putative
`ARES, defined as 5'-UAUUUAUU-3’ and 5'-UUAUU
`UAU-S’ octamer sequences, located within 500 nucleo—
`tides after the translation termination codon (Table 1).
`To test whether Cth2-dependent mRNA downregulation
`during Fe deficiency occurs via ARES located within the
`3'UTR, we used the mRNA encoding the membrane-
`anchored heme'containing subunit of the succinate de-
`hydrogenase complex in mitochondria, SDH4, which is
`downregulated under Fe deprivation in a manner com-
`pletely dependent on 0ch (Figures 30 and 3F). The
`SDH4 3’UTFI contains three 5’-UUAUUUAUU-3’ se-
`quences beginning at 125, 135, and 158 nucleotides
`afterthe translation termination codon (Table 1 and Fig-
`ure 4A). The adenine nucleotides 127, 134, 141, and 160
`were mutated to cytosine in a plasmid-borne copy of
`the SDH4 gene (Figures 4A and 4B, SDH4-AREmt2) and
`mFlNA levels assessed under high and low Fe conditions
`
`

`

`Cth2 Controls 3 Posttranscn'ptional Fe Regulon
`1 03
`
`
`Putative AREs
`ORF
`Geno
`Function
`Fold : SD
`iron reguion
`YDR5346
`YOR382W
`YLR2OSC
`Heme biosynthesis
`YDR044W
`YOR176W
`
`Cell wall mannoprotein involved in sideroohore-Fe uptake
`Cell wall mannoprotein involved in siderophore-Fe uptake
`Home binding peroxidase involved in reuliiization of heme Fe
`
`2.0 :t 0.2
`1.6 1 0.1
`2.0 i 0.4
`
`263
`255
`
`Coproporphyrinogen Ill oxidase, oxygen-requiring enzyme
`Ferrochelatase, catalyzes insertion of Fe(ll) into
`protoporphyrin IX
`
`1.5 :t'. 0.3“
`2.2 1 0.2
`
`68, 89
`43, 99
`
`FiT1
`FiT2
`HMX1
`
`HEM13
`HEM15
`
`2.0 1 0.2
`1.9 + 0.1
`
`2.0 :c 0.2
`1 .7 .1- 0.4
`2.6 1: 0.3
`1.6 t 0.2
`1.8 t 0.2
`2.8 :- 0.8
`3.2 1 0.7
`
`1.6 x 0.2
`
`1.9 :l: 0.4
`2.2 I 0.2
`1.9 r 0.2
`1.8 1- 0.2
`
`2.0 i 0.2
`1.6 :r 0.2
`1.7 3: 0.3
`1.9 i 0.2
`1.8 1 0.3
`2.0 tr 0.1
`
`2.1 3: 0.2
`1.7 :1.- 0.3
`2.8 :r. 0.5
`1.6 r 0.2
`1.6 1 0.2
`
`2.0 3: 0.3
`1.6 't 0.1
`1.6 t 0.1
`1.7 I 0.4
`1.6 a“. 0.3
`
`191, 203
`46, 62
`
`32, 150, 177
`193, 230
`242
`162, 309, 328
`125, 135, 158
`
`53
`88
`104
`44
`
`140
`155
`31
`150, 239
`97, 114
`293, 355
`
`13. 37, 81
`42
`18, 41, 50, 59
`
`4, 60
`174, 203, 273
`19
`
`52
`
`1.6 i: 0.3
`1.7 + 0.2
`1.6 1 0.1
`
`151, 187
`89, 105
`18, 148
`
`1.4 t 0.2'
`1.6 t 0.4
`
`68
`39, 125
`
`1.4 :: 0.1 "
`2.0 x 0.3
`1.7 .t 0.3
`1.6 i 0.2
`1.7 2‘: 0.3
`1.6 f". 0.4
`1.7 i 0.2
`1.6 1" 0.2
`
`24, 144
`70, 92
`B5, 123
`280, 291
`275, 303
`
`16
`
`Fe~S cluster biogenesis
`YKLMOC
`NFU1
`YL£027W
`ISM
`TCA cycle
`YNR001C
`YPR001W
`YL3304C
`Yll..1 25W
`YDm 48C)
`YLL041C
`YDR178W
`
`(3111
`GETS
`A001
`KGDi
`K602
`SDH2
`SDH4
`
`NifU-like protein
`Member of Fo-S cluster biosynthesis machinery
`
`Subunit N of cytochrome c oxidase
`Subunit Vi of cytochrome c oxidase
`Subunit Vii! of cytochrome c oxidase
`Subunit Vila of cytochrome c oxidase
`
`Citrate synthase
`Mitochondrial isoiorm of citrate synthase
`Mitochondrial aconitase, Fe~s cluster protein
`Alpha-ketoglutarate dehydrogcnztse
`Dihydroiipoyi transsuccinyiasc
`Succinate dehydrogenase (ubiquinone) res cluster subunit
`Succinate dehydrogenase membrane anchor heme-binding
`subunk
`Mitochondrial and cytoplasmic iumarase, Fe-S cluster protein
`FUM1
`YPL262W
`Mitochondrial respiration/electron transport chain
`Cytochrome c oxidase
`YGL187’C
`COX4
`YHR051W
`COXB
`YLRSQSC
`COXB
`YDL067C
`COXS}
`Ubiquinoi cytochrome :2 reductase
`YBL045C
`(tom/com Core subunit l of ubiquinol cytochrome (2 reductase complex
`YPR191W
`QCRZ/CORZ
`Core subunit ll of ubiquinoi cytochrome (2 reductase complex
`YFFlOSSC
`QCRG/COR3
`Subunit Vi of ubiquinoi cytochrome c reductase complex
`YDRSEQC
`001271130114
`Subunit Vii of ubiquinol cytochrome c reduclase complex
`YJL166W
`QCRS/CORS
`Subunit Viil of ubiquinol cytochrome c reductase complex
`YEL024W
`RIF-’1
`Rieske Fe-S protein oi ubiquinol cytochrome c reduc’tase
`complex
`Putative mitochondrial dehydrogenase fiavoprotein
`YORSSSW
`Flavinudependent monooxygenase, ubiquinone biosynihesis
`COOS
`YGR2550
`Cytochrome c peroxidase
`CCPi
`YKR0660
`NADH dehydrogenase
`N051
`YMRMSC
`Mitochondrial ADP/ATP carrier
`PETQ/AACZ
`YBL0300
`Steroi and fatty acid synthesis and metabolism
`YHRO72W
`ERG?
`Lanosteroi syathaso
`YHROO7C
`ERGH
`Lanosteroi C-1 4 demelhyiase
`YMR208W
`ERG12
`Mevalonate kinase
`YGROSOW
`ERGZS
`(3—4 methyl steroi oxidase
`YERDMC
`ERG28
`ER membrane protein, may facilitate Erg26 and Erg27
`interactions
`Fatty acid desaturase
`Hydroxylalion of C-26 fatty acid in ceramide
`Damage response protein involved in stem! synthesis
`
`OLE1
`YGLOSSW
`FAHVSCS?
`YMR272C
`DAP1
`YPLWOW
`DNA replication and repair
`Ribonucleotide-diphosphate reductase, di«Fe—tyrosyl coiactor
`YJL026W
`RNRZ
`Ribonuclemidediphosphate reductase, Y4 subunit
`YGR1BOC
`RNR4
`Other Fe-, Cu». and oxygen-related function
`YLR220W
`(3061
`Transporter that mediates vacuolar Fe storage
`YOR19£SC
`LIPS
`Lipoic acid synthase. Fe~S cluster protein
`YGLOOQC
`LEU1
`lsopropylmalate isomerase, Fe—S oiuster protein
`YDROQ1 C
`RLH
`RNase 1. inhibitor, Fo~S cluster protein
`YKL109W
`HAP4
`Subunit of Hap transcriptional activator
`YHR055C
`CUP1~2
`Copper-binding metallothionoin
`YAROZOC
`PAU?
`Member of PAU family
`YORSSMW
`Member of PAU family
`Other functions
`1.6 i 0.3
`Nonmitochondriai citrate synthase
`0sz
`YCHOOSC
`1.8 .x 0.2
`Phosphoribosylanihranilate isomerase
`TFlP‘i
`YDROGYW
`1.6 t 0.3
`Leucine zipper transcriptional activator
`CAD1
`YDR423G
`54
`1.6 i 0.2
`Phosphomannose isomerase
`PMMO
`YEROOGG
`YHROOZW
`
`
`Mitochondrial carrier proteinLEU5 1.6 2; 0.3
`
`
`

`

`Cell
`
`Table 1. Continued
`
`
`
`
`
`Function
`
` Fold 2 so ORF Gene Putative AREs
`Other functions
`YJL172W
`YJR016C
`YLR121C
`YML028W
`YOFl230W
`YPL053C
`YPL1540
`Unknown function
`YBL048W
`YBR187W
`YCR017C
`YDR36GC
`YDR411C
`YER048W—A
`YER138W-A
`YER15SC
`YGL002W
`YGL1886
`YHRO45W
`YHR113W
`YJL171C
`YKR103W
`YKR104W
`YLROBSC
`YLR251W
`YMLOBQC
`YMR041C
`YMR11OC
`YNL320W
`YOL083W
`YOLOQZW
`YOR214C
`YORSOGC
`YPL2500
`YPR002W
`
`1.7 i 0.1
`1.6 I 0.2
`1.7 t 0.2
`2.0 t 0.2
`2.3 i 0.2
`1.6 i 0.2
`1.9 i 0.3
`
`1.3 : Of:
`1.8 t 0.1
`1.6 t 0.3
`1.6 i 0.2
`1.8 r 0.2
`1.6 :- 0.3
`1.7 :t 0.3
`1.8 i 0.3
`1.7 t 0.1
`1.7 t 0.1
`1.7 1- 0.2
`1.9 ft 0.1
`1.7 r 0.2
`3.3 x 0.4
`3.6 t 0.7
`1.6 1*. 0.2
`1.6 1 0.2
`1.8 :t 0.2
`1.6 r 0.3
`1.7 '3; 0.3
`1.9 :— 02
`1.8 t 0.3
`1.8 i 0.1
`1.6 :5 0.2
`1 .6 i 0.1
`1 .6 f. 0.1
`2.0 i 0.3
`
`98
`314
`
`145
`62
`
`109
`
`59
`71
`
`19
`33
`81
`
`43, 194
`
`327
`83
`92
`52
`15
`
`
`198
`
`CPS1
`lLV3
`YPSS
`TSAt
`WTMt
`KTRS
`PEP4
`
`509.413
`
`CWH43
`
`DFM1
`
`ERPS
`
`NFTt
`NFTi
`EMP70
`SYM1
`
`MCH5
`lCY2
`PDH1
`
`Vacuolar carboxypeptidase
`Dihydroxyacid dehydratase
`GPlvanchored aspartic protease
`Thioredoxin-persxidase
`WD repeat containing transca'ptional modulator I
`Mannosylphosphate transferase
`Vacuolar proteinase A
`
`Unknown function
`Unknown function
`Putative sensor/transporter protein
`Unknown function
`Den-like family member
`Unknown function
`Unknown function
`Unknown function
`Member of p24 family
`Unknown function
`Unknown function
`Putative vacuolar aminopeptidase
`Unknown function
`Merged with YKR104 in some backgrounds
`Putative MRP-type ABC transporter
`Endosomal membrane protein
`Stress-induced yeast MPV17 homologue
`Unknown function
`Unknown function
`Unknown function
`Unknown function
`Unknown function
`Unknown function
`Unknown function
`Monocar’ooxylate permease homologue
`interacts with the cytoskeleton
`
`Homologue to E. coli prpD
`
`
`
`cfh1cth2 cells expressing CTH2 or vector alone were independently grown by triplicate in the presesce of 100 uM BPS (Fe depletion) until
`exponential cell phase; RNA was extsacted, labeled, and hybridized to yeast DNA microarrays as described in Bperémental Procedures. The
`gene expression profile of cells containing vector alone versus expressing CTH2 (cth2 versus CTHZ was determined and the average fold
`induction represented. Only mRNAs with a fold induction in the cth2 mutant higher than 15-fold and a p value < 0.05 are shown. ORF,
`open reading frame systematic name; gene, common name; function, description of the biological function of the protein according to the
`Saccharomyces Genome Database, published data, and sequence homology; ARES. AU-rich elements (5’—UUAUUUAUU-3’ nonarner sequence)
`positioned within the 500 nucleotides after translation termination codon. 5’-UAUUUAUU-3' and 5'-UUAUUUAU—3‘ octamers were indicated
`in italics. SD, standard deviation. The complete set of data is available at http://data.cgt,duke.edufiron.php.
`‘Genes below the cutoff but confirmed by RNA blotting analysis.
`
`by RNA blotting. As shown in Figure 4C, wild-type SDH4
`mRNA levels are dramatécally downregulated under Fe
`depletion, while SDH4-AREmt2 mRNA levels are unaf-
`fected by Fe. Furthermore, downregulation of CCC1
`mRNA by Fe depletion was also completely dependent
`on the 3'UTR (Supplemental Figure 83). Taken together,
`these results demonstrate that CTH2—dependent mRNA
`downregulation under low Fe conditions is dependent
`on the presence of specific AREs located in the 3’UTR.
`To ascertain whether ARES are sufficient for mRNA
`downregulation in response to Fe deprivation, chimeric
`transcripts were expressed that contain the coding se—
`quence of GCN4, a gene not regulated by Cth2 (data
`not shown), and the 3’UTR from either SDH4 or ACO1
`(Figures 4A and 4D), two genes whose mRNA steady-
`state levels are regulated by Cth2. While wild-type GCN4
`mRNA levels were not significantly decreased by Fe
`
`starvation, GCN4-ACO1-3’UTR mRNA was dramatically
`downregulated under Fe deprivation (Figure 4E). A simi-
`lar result was obtained when the 3'UTR of the SDH4
`mRNA was fused to GCN4 (Figure 4E). lmportantly, mu-
`tagenesis of the ARES in the SDH4-3’UTR abrogated
`the Fe dependent downregulation of GCN4-SDH4-
`3’UTR mRNA (Figure 4E, GCN4-SDH4-AREmt2). In addi-
`tion, the downregulation of both GCN4-ACOi-3’UTR
`and GCN4-SDH4—3’UTR mRNAs was completely de-
`pendent of the presence of a functional Cth2 protein
`(Figure 4F). cth1cth29cn4 mutants expressing either
`GCN4-ACO1-3’UTR or GCN4-SDH4»3’UTH were cotrans-
`fomied with vector, wild-type CTH2, or the CTH2-C190Fl
`mutant. As shown in Figure 4F, the Fe starvation-depen-
`dent decrease in steady-state levels for both mRNA
`species was abrogated in cells lacking CTH2 (vector
`lanes) and in cells with a nonfunctional allele of CTH2
`
`

`

`1
`0622 Controls a Posttranscriptional Fe Regulon
`
`A
`
`i3
`
`C
`
`SDH4-3’ Region
`
`
`
`
`
`T
`ORF
`
`i som'ma.
`”2;; ease
`
`”gig/g?
`
`SDH4-AREth
`
`SDH4
`SDH4 k’REmtz
`l—1F—l.
`
`
`
` GCN4-SDH4
`
`'
`
`;. GCN4-SDH4mt2
`
`gc'n4
`
`GCN4
`GCN4 SDH4
`GCN4
`GCN4 ACO1 GCN4 SDH4-AREmtz
`r———rr—""Ir——Ir--—II—1
`F'e+-+-+-’+-+-
`
`
`
`cth1’cth29cn4
`y—‘WM
`GCN4-SDH4 3'UTR GCN4-ACO1 3’UTR
`r-—----—-1 r———-’——"—"1
`CTH2 vectorC190R' CTHZ vector C1907?
`
`
`
`Figure 4. ARES in the 3'UTR of CTHZ Targets Induce mRNA Destabilization of a Reporter Gene under Fe Scarcity
`(A) Sequence of the 3’ region of SDH4 and ACO1 genes. Putative AREs are shown underlined. SDH4-3'UTR adenine residues mutagenized
`to cytosine in GCN4-SDH4-AREmt2 are shown in bold characters.
`(B) Schematic representation of wild-type SDH4 and SDH4-3’UTR mutant 2 (SDH4-AREmt2).
`he ARES located in the 3’UTFl. sdh4 cells expressing SDH4 and SDH4-
`(G) SDH4 downregulation in low Fe is dependent on the integrity of t
`AREth were grown and analyzed by RNA blotting as described in Figure SC.
`(D) Schematic representation ofwild-type GCN4 and GCN4 with 3'UTR replaced byACO1-3’UTH(GCN44A001), wild—type SDH4—31F“? (GCN4-
`SDH4), and mutant SDH4-ARE-mt2 (GCN4-SDH4mQ).
`(E) gcn4 cells expressing GCN4, GCN4-ACO1-3’UTH, GCN4oSDH4-3’UTR, and GCN4-SDH4—AREmt2 were grown in SC-Ura media (Fe +) and
`SC-Ura containing 100 ”M BPS (Fe -) and analyzed by RNA blotting with GCN4 and ACT1 probes.
`(F) cth1cchgcn4 cells expressing either GCN4—SDH4-3'UTR or GCN4-ACO1-3’UTR were transformed with vector alone or containing CTH2
`or CTH2-0190!? mutant allele and grown and analyzed by RNA blotting as described (E).
`
`(C1903 lanes). Taken together, these results demon—
`strate that the AREs found in the 3’UTR of both ACO1
`and SDH4 are necessary and sufficient to induce the
`CTH2 and Fe limitation-dependent downregulation of
`GCN4 mRNA.
`
`Cth2 Accelerates the Rate of mRNA Decay
`Our data strongly implicate Cth2 and 3’UTR ARES in the
`coordinated downregulation of specific mRNAs by Fe
`deprivation. Steady-state mRNA measurements are the
`net consequence of both transcription and the rate of
`mRNA decay, and our analyses are consistent with Cth2
`acting at a posttranscriptéonal level. To evaluate the effects
`of 0ch on mRNA decay rates, two Cth2—dependent target
`mRNAs were conditionally expressed in yeast using the
`galactose-inducible and glucose-repressible GAL1 pro-
`moter. cth1cth29¢n4 cells were cotransformed with
`GCN4-AC01-3'UTR or GCN4-SDH4-3'UTR constructs
`dréven by the GAL1 promoter (Figure 5) and plasmid-
`bome CTH2 or empty vector. Cells were grown in galac-
`
`tose and the Fe chelator BPS to induce transcription
`of GCN4-ACO1/SDH4-3’UTR and CTHZ, respectively.
`Transcription of the GCN4-ACO1 or GCN4vSDH4-3’UTR
`genes was shut off by gluc05e addition and mRNA levels
`analyzed over time by RNA blotting (Figure 5). The half-
`life of GCN4—ACO1—3’UTR mRNA decreased from 7 min
`to 3 min when CTH2 was expressed (Figure 5A). A similar
`decrease in the half-life, from 9 to 4 min, was observed
`for GCN4-SDH4-3'UTFl mRNA in cells expressing CTH2
`(Figure SB). No change in mRNA half-life was observed
`when the cells expressed the CTHZ-Ci'QOR mutant allele
`or when they were grown in the presence of Fe, condi-
`tions that severely repress the expression of CTH2 (data
`not shown). Furthermore, while the half-life of a mRNA
`including the SDH4 codéng sequence and 3'UTR was
`7 min in wild-type cells growing under Fe-deficient con-
`ditions, it increased to 14 min in either cells lacking CTHZ,
`wild-type cells grown in Fe-replete conditions, or in CFH2
`wild-type cells expressing SDH4 mRNA with mutated
`ARES (Figure 50). Similar results were obtained for the
`
`

`

`Promote?
`cg]:
`3mm
`
`a
`str_
`
`
`W Haif-lif'e
`
`CTHz
`
`Vector
`
`\
`
`
`
`3
`
`?
`
`Z2“? ”iii:
`
`mrahzsdm
`
`9 5 1o 15- 20
`
`(mini
`
`
`
`
`vector
`
`-Fe
`
`'c-TH2
`
`-Fe
`
`SDI-l4
`
`sum
`
`mm '+ Fe
`
`sum
`
`cer
`
`~Fe st-
`AREmt2
`
`14
`
`7'
`
`14
`
`14
`
`Cell
`106
`
`A
`
`B
`
`Promoter
`ORF
`
`
`
`promoter
`ORF
`sum
`éfita
`CCP1
`"*””
`
`
`Min-(after shutoff
`.0 5_.10 1-5 20
`
`Bait-life
`(min)
`
`
`
`vector
`
`cthmmc-CP’
`
`Min. after shutoff
`o a 10 15 20 30
`
`Half-fife
`(min)
`
`vector
`
`CTHZ
`
`-Fe
`
`
`- Fe WW Wt;
`
`.
`
`..
`
`“WM-win
`
`17
`
`11
`
`Worm 637;” as assess w 18
`
`Figure 5. Cth2 Accelerates the Decay of

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket